ABCELLERA BIOLOGICS Asset Resilience Ratio

Latest as of June 2026: 32.12%

ABCELLERA BIOLOGICS asset resilience ratio. ABCELLERA BIOLOGICS (8QQ) has an Asset Resilience Ratio of 32.12% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ABCELLERA BIOLOGICS (8QQ) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€420.04 Million

≈ $491.07 Million USD Cash + Short-term Investments

Total Assets

€1.31 Billion

≈ $1.53 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of ABCELLERA BIOLOGICS (2021–2025)

Asset resilience ratio of ABCELLERA BIOLOGICS from 2021 to 2025. This chart shows how ABCELLERA BIOLOGICS's Asset Resilience Ratio has changed over time. Read debt load of ABCELLERA BIOLOGICS for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down ABCELLERA BIOLOGICS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 8QQ total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€420.04 Million	32.12%
Total Liquid Assets	€420.04 Million	32.12%

Asset Resilience Insights

Very High Liquidity: ABCELLERA BIOLOGICS maintains exceptional liquid asset reserves at 32.12% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

ABCELLERA BIOLOGICS Industry Peers by Asset Resilience Ratio

Compare ABCELLERA BIOLOGICS's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Achieve Life Sciences Inc F:SP4P	Biotechnology	3.60%

ABCELLERA BIOLOGICS Asset Resilience Ratio by Year (2021–2025)

ABCELLERA BIOLOGICS asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for ABCELLERA BIOLOGICS.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	29.87%	€405.31 Million ≈ $473.85 Million	€1.36 Billion ≈ $1.59 Billion	-4.62pp
2024-12-31	34.49%	€469.29 Million ≈ $548.65 Million	€1.36 Billion ≈ $1.59 Billion	-7.66pp
2023-12-31	42.15%	€627.26 Million ≈ $733.34 Million	€1.49 Billion ≈ $1.74 Billion	+9.71pp
2022-12-31	32.45%	€499.95 Million ≈ $584.49 Million	€1.54 Billion ≈ $1.80 Billion	+13.73pp
2021-12-31	18.72%	€246.84 Million ≈ $288.58 Million	€1.32 Billion ≈ $1.54 Billion	--

pp = percentage points

About ABCELLERA BIOLOGICS

F:8QQ Germany Biotechnology

Market Cap

$4.02 Billion

€3.43 Billion EUR

Market Cap Rank

#4623 Global

#796 in Germany

Share Price

€10.60

Change (1 day)

-6.19%

52-Week Range

€2.49 - €12.80

All Time High

€44.98